Keynote two

We are excited to announce that the second keynote of #EBW26 will be delivered by Aneta Tyszkiewicz, Director, Science and Regulatory at the European Federation of Pharmaceutical Industries and Associations (EFPIA). The subject of the keynote will be ‘From scientific excellence to industrial leadership: Strengthening Europe’s attractiveness for research and innovation through the EU Biotech Act’.

Europe stands at a pivotal moment in global biotechnology. While its scientific base remains strong, fragmentation, insufficient investment and regulatory complexity risk undermining its competitiveness.

The Biotech Act offers a unique opportunity to create a coherent, innovation-friendly ecosystem that enables research, development and manufacturing to scale in Europe. To deliver, it must combine effective incentives, a truly harmonised clinical trials system, regulatory simplification, strategic investment and a robust framework for data and AI.

With the right ambition, Europe can move beyond incremental change and position itself as a global leader in biotechnology, ensuring faster patient access and long-term economic growth.